Ana Mingorance | Principal
Dracaena Consulting

Ana Mingorance, Principal, Dracaena Consulting

Dr. Ana Mingorance is a specialist in genetic epilepsy syndromes and an independent consultant in CNS and orphan drug development. Ana has close relationships with patient groups and has acted as a scientist-in-residence, scientific advisor, and patient advocate. She is the author of the eBook #ImpatientRevolution about patient group involvement in drug development. Ana is a Scientific Advisor to the Dravet Syndrome European Federation and former Scientific Director of the Dravet Syndrome Foundation Spain, where she built and managed a portfolio of research collaborations ranging from diagnostics to clinical research. Before that, Ana was a laboratory head and discovery project leader at the global biopharmaceutical company UCB Pharma in Belgium. She received her PhD in Neuroscience from the University of Barcelona in Spain and completed an EMBO Postdoctoral Fellowship at the University of British Columbia in Canada.


Day 1 Orphan 14th Nov @ 14:45

The evolving orphan drug development model: how the business case to pursue a disease changes over time

back to speakers